Literature DB >> 25601417

A novel homozygous mutation in the SLCO2A1 gene is associated with severe primary hypertrophic osteoarthropathy phenotype in a Saudi patient.

Nedhal Ayoub1, Sultan Al-Khenaizan1,2, Haitham Sonbol3, Rakan Albreakan4, Mohammed AlSufyani5, Mohammed AlBalwi2,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25601417     DOI： 10.1111/ijd.12770

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

Review 1.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

2.  Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer.

Authors:  Yu-Hung Fang; Chien-Chin Hsu; Meng-Jer Hsieh; Ming-Szu Hung; Ying-Huang Tsai; Yu-Ching Lin
Journal:  Onco Targets Ther       Date:  2017-10-25       Impact factor: 4.147

3.  Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.

Authors:  Sihoon Lee; So Young Park; Hyun Jin Kwon; Chul-Ho Lee; Ok-Hwa Kim; Yumie Rhee
Journal:  J Korean Med Sci       Date:  2016-03-22       Impact factor: 2.153

4.  Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.

Authors:  Lijuan Yuan; Xihui Chen; Ziyu Liu; Dan Wu; Jianguo Lu; Guoqiang Bao; Sijia Zhang; lIfeng Wang; Yuanming Wu
Journal:  Endocr Connect       Date:  2018-08-01       Impact factor: 3.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.